Page 41 - ட்ரெக்செல் பல்கலைக்கழகம் கல்லூரி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U.S. lifts pause, allowing Johnson & Johnson COVID-19 vaccinations to resume CDC advisers said Friday the benefits of the single-dose shot outweigh a rare risk of blood clots. File photo.(Mark Lennihan) By Wire Services 4:05 PM on Apr 23, 2021 CDT Updated at 6:02 PM on Apr 23, 2021 CDT Revised to reflect health officials lifting the pause. U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized.

United statesRochelle walenskyCatherine marfinWilliam schaffnerCenters for diseaseShore university hospital in bayDrug administrationVanderbilt universityDisease controlSarah longDrexel university collegeSouth shore university hospitalBay shoreEmergent biosciencesஒன்றுபட்டது மாநிலங்களில்வில்லியம் ஶஃப்நர்